• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

AD Manager

anonymous

Guest
Northwest Manager is by far the most worst leader in Derm. Two entire PS districts dislike him with a passion and members on his team are already looking for better opportunities. No amount of money is worth working for such a jerk at Abbvie. The representatives that were not assigned to this guy are so grateful to avoid that nightmare.